Medical Insights from Industry

RSS

"Insights from Industry" is a dynamic series of interviews at the cutting edge of the medical industry. Every interviewee is a leader in their particular field and is handpicked to give an informative and accessible insight into their chosen field. These interviews are guaranteed to keep you in the know in a rapidly changing industry.

Long-term treatment of GERD: an interview with Chris Rowland, CEO, Medigus

To control reflux symptoms, many people take acid-controlling medications such as Proton Pump Inhibitors, or PPIs. The FDA, however, has issued warnings over the frequent or long-term continued use of PPIs...

18 May 2015

ICD-10 Clinical Modification: an interview with Dr. Jon Elion, Founder, ChartWise Medical Systems

ICD-10 is the tenth revision to the World Health Organization’s (WHO) International Classification of Diseases. ICD-10, like its predecessor, ICD-9, is based on a set of unique alphanumeric codes to identify known diseases and other health problems...

29 Apr 2015

Advances in thoracic surgery: an interview with Dan Wildman, VP Global Franchise Strategy & Innovation- Ethicon

Without a doubt, one of the most significant developments in thoracic surgery was the advent of video-assisted thoracoscopic surgery or VATS in the 1990s...

22 Apr 2015

Countering Ebola misinformation: an interview with Dr Katie Geary, International SOS

People tried to avoid a healthcare situation and in doing so, they propagated it through the community because instead of being in isolation they remained around the family group and relied on usual cultural health remedies...

20 Apr 2015

Warfarin and PT-INR testing: an interview with Paul Wright, CEO, Universal Biosensors

There are roughly 10 million people worldwide taking Warfarin, accounting for more than 200 million point of care (POC) PT-INR tests performed globally each year...

15 Apr 2015

Detecting bladder cancer from urine: an interview with Suzana Nahum-Zilberberg, CEO, BioLight

Bladder cancer is the seventh leading cancer affecting men worldwide and in the United States, it is the fourth leading cancer. Each year, about 350,000 cases are being detected worldwide, and the disease claims 165,000 lives every year.

31 Mar 2015

Improving adherence to ulcerative colitis medications: an interview with Mattias Norrman, COO, Tillotts Pharma

The objective of the survey was two-sided. On one side, we wanted to better understand needs, concerns and attitudes of people with UC in an effort to identify solutions to improve the management of the disease. On the other, we wanted to build a questionnaire that could be used by HCPs to help define patients’ needs and concerns.

17 Mar 2015

Nuclear medicine in Australia: an interview with Doug Cubbin, ANM Board Chairman

Molybdennum-99 is a central part of Australia’s modern medical system, and is by far the most commonly used radioisotope produced by ANSTO. It decays to Technetium-99m, which is potentially lifesaving as it is used in the diagnosis of heart, conditions, as well as diagnostic procedures associated with kidneys, lungs, bone and the liver.

10 Mar 2015

Blood gas testing: an interview with David Stein, PhD, CEO, Point of Care, Siemens Healthcare Diagnostics

The industry term ‘blood gas testing’ has come to mean the accurate measurement and reporting of a wide menu of blood parameters, all on a single platform.

From Siemens Healthineers Point of Care Diagnostics 9 Mar 2015

Psoriasis management: an interview with Dr Sandy McBride

A major challenge around treating psoriasis is communication - psoriasis can flare and resolve in between appointments so it can be difficult to express and describe the life impact of these flares and recall possible triggers and response to treatments. People with psoriasis can also find it very difficult to talk about their emotions – something known as alexithymia – again making it difficult for clinicians to fully appreciate the impact of psoriasis.

25 Feb 2015

BRCA1/2 analysis: an interview with Jurgi Camblong, CEO of Sophia Genetics

BRCA1 and BRCA2 genes are two of the most well studied genes in the cancer field. They are tumor suppressors - mutations in these genes can lead to breast and/or ovarian cancer. Predispositions can be detected in women before they develop cancer.

26 Jan 2015

Using breath tests to diagnose liver diseases: an interview with Larry Cohen

It was back in the 1960s that scientists first started to understand that breath could be used to find out different things about diseases and other factors. I’m sure you’re familiar with alcohol breath testing, which was patented back in the ‘50s and has been used since the ‘60s.

19 Jan 2015

Interactive virtual human body: an interview with Frank Sculli, CEO, BioDigital

The BioDigital Human is an interactive, virtual model of the human body that addresses huge deficiencies in health education and communication. From diagnosis to drugs to devices, the human provides an engaging way to really understand complex health information.

13 Jan 2015

Digital healthcare communications: an interview with David Hunt, CEO of HAVAS LYNX Europe

$Using Refractory Metals in Cancer Treatments$

Using Refractory Metals in Cancer Treatments

This interview discusses how refractory metals can be used in cancer treatments.

From H.C. Starck Solutions 10 Dec 2014

Continuous glucose monitoring (CGM) mobile communications: an interview with Jorge Valdes

Type 1 diabetes is a complex condition to manage. It requires continuous, around the clock monitoring of blood glucose levels, which change repeatedly throughout the day and night.

7 Dec 2014

Medical Insights from Industry

Long-term treatment of GERD: an interview with Chris Rowland, CEO, Medigus

ICD-10 Clinical Modification: an interview with Dr. Jon Elion, Founder, ChartWise Medical Systems

Advances in thoracic surgery: an interview with Dan Wildman, VP Global Franchise Strategy & Innovation- Ethicon

Countering Ebola misinformation: an interview with Dr Katie Geary, International SOS

Warfarin and PT-INR testing: an interview with Paul Wright, CEO, Universal Biosensors

Detecting bladder cancer from urine: an interview with Suzana Nahum-Zilberberg, CEO, BioLight

Improving adherence to ulcerative colitis medications: an interview with Mattias Norrman, COO, Tillotts Pharma

Nuclear medicine in Australia: an interview with Doug Cubbin, ANM Board Chairman

Blood gas testing: an interview with David Stein, PhD, CEO, Point of Care, Siemens Healthcare Diagnostics

Psoriasis management: an interview with Dr Sandy McBride

BRCA1/2 analysis: an interview with Jurgi Camblong, CEO of Sophia Genetics

Using breath tests to diagnose liver diseases: an interview with Larry Cohen

Interactive virtual human body: an interview with Frank Sculli, CEO, BioDigital

Digital healthcare communications: an interview with David Hunt, CEO of HAVAS LYNX Europe

Neurological testing accessibility and affordability: an interview with Dr Joseph Higgins

Hospital treatment far from home: an interview with Paul Lindsell, Managing Director at MindMetre Research

Lung cancer in women: an interview with Harold Wimmer and Chuck Brynelsen

Wearable technology and data analytics in healthcare: an interview with Mark Taglietti and Bob Zemke

Using Refractory Metals in Cancer Treatments

Continuous glucose monitoring (CGM) mobile communications: an interview with Jorge Valdes

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Latest News